Health & Environmental Research Online (HERO)


Print Feedback Export to File
2850183 
Journal Article 
Protein binding associated with exposure to fluorotelomer alcohols (FTOHs) and polyfluoroalkyl phosphate esters (PAPs) in rats 
Rand, AA; Mabury, SA 
2014 
Yes 
Environmental Science and Technology
ISSN: 0013-936X
EISSN: 1520-5851 
48 
2421-2429 
English 
is supplemented by 3980901 : Supplementary materials
The biotransformation of fluorotelomer-based compounds such as fluorotelomer alcohols (FTOHs) and polyfluoroalkyl phosphate esters (PAPs) are sources of exposure to perfluorinated carboxylates (PFCAs), leading in part to the observation of significant concentrations of PFCAs in human blood. The biotransformation of FTOHs and PAPs yield intermediate metabolites that have been observed to covalently modify proteins. In the current investigation, the extent of covalent protein binding in Sprague-Dawley rats upon exposure to 8:2 FTOH and the 6:2 polyfluoroalkyl phosphate diester (6:2 diPAP) was quantified. The animals were administered a single dose of 8:2 FTOH or 6:2 diPAP at 100 mg/kg by oral gavage to monitor biotransformation and extent of protein binding within the liver, kidney, and plasma. In the 8:2 FTOH-dosed animals, perfluorooctanoate (PFOA) was produced as the primary PFCA, at 623.13 ± 59.3, 459.5 ± 171.8, and 397.3 ± 133.0 ng/g in the plasma, liver, and kidney, respectively. For the animals exposed to 6:2 diPAPs, perfluorohexanoate (PFHxA) was the primary PFCA produced, with maximum concentrations of 57.4 ± 6.5, 9.0 ± 1.2, and 25.3 ± 1.2 ng/g in the plasma, liver, and kidney, respectively. Protein binding was observed in the plasma, liver, and kidney after 8:2 FTOH and 6:2 diPAP exposure, with the most significant binding occurring in the liver (>100 nmol/g protein). This is the first study to link the exposure and in vivo biotransformation of fluorotelomer-based compounds to covalent protein binding. 
PFAS
• 6:2/8:2 diPAP
     Literature Search
          Pubmed
          WOS
     Screening Results
          Excluded/Not on Topic
• 6:2 diPAP
     Literature Search
          Pubmed
          WOS
     Screening Results
          In vivo animal studies
               Other
          Toxicokinetic studies
               ADME
• 8:2 diPAP
     Literature Search
          Pubmed
          WOS
     Screening Results
          Excluded/Not on Topic
• FtOH 6:2
     Screening Results
          Excluded/Not on Topic
• FtOH 8:2
     Literature Search
          Pubmed
          WOS
     Screening Results
          In vivo animal studies
               Other
          Toxicokinetic studies
               ADME
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFHxA (307-24-4)
          Literature Search
               Pubmed
               WOS
     FtOH 8:2 (678-39-7)
          Literature Search
               Pubmed
               WOS
     FtOH 6:2 (647-42-7)
          Literature Search
               Pubmed
     6:2 diPAP (57677-95-9)
          Literature Search
               Pubmed
               WOS
     8:2 diPAP (678-41-1)
          Literature Search
               Pubmed
               WOS
     6:2/8:2 diPAP (943913-15-3)
          Literature Search
               Pubmed
               WOS
• PFHxA
     Literature Search
          Pubmed
          WOS
     Literature Search: February 2018 Update
          Term Set 2: Initial Search
               PubMed
               WoS
     Screening Results
          Excluded/Not on Topic
     Title and Abstract Screening
          Excluded
               Not relevant to PECO
     Literature Search
          Pubmed
          WOS
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search Update (2013-2019)
          PubMed
          WOS